Johnson & Johnson Beat Expectations

Johnson & Johnson (JNJ) reported earnings of $2.77 per share on revenue of $23.74 billion for the second quarter ended June 2025. The consensus earnings estimate was $2.66 per share on revenue of $22.79 billion. The Earnings Whisper number was $2.74 per share. The company beat expectations by 1.09% while revenue grew 5.77% on a year-over-year basis.

The company said it expects 2025 earnings of $10.80 to $10.90 per share on revenue of $93.20 billion to $93.60 billion. The company's previous guidance was earnings of $10.50 to $10.70 per share on revenue of $91.0 billion to $91.8 billion and the current consensus earnings estimate is $10.64 per share on revenue of $91.29 billion for the year ending December 31, 2025.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices, and Diagnostics business segments.